Giovanni Martinelli, MD^1*, Hervé Dombret², Patrice Chevallier, MD, PhD^3*, Oliver G. Ottmann, MD^4*, Nicola Goekbuget, MD⁵, Max S. Topp, MD⁶, Adele K. Fielding, MB BS, PhD⁷, Lulu Ren Sterling, PhD^8*, Jonathan Benjamin, MD⁹ and Anthony Selwyn Stein, MD¹⁰

¹Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
²Hematology, Hôpital Saint-Louis, Paris, France
³Department of Hematology, Nantes University Hospital, Nantes, France
⁴Department of Haematology, Cardiff University, Cardiff, United Kingdom
⁵Department of Medicine II, Goethe University, Frankfurt, Germany
⁶Department of Internal Medicine II, Division of Hematology and Medical Oncology, Wuerzburg University Medical Center, Wuerzburg, Germany
⁷Department of Hematology, UCL Cancer Institute, London, United Kingdom
⁸Amgen Inc., San Francisco, CA
⁹Amgen Inc., Thousand Oaks, CA
¹⁰Gehr Leukemia Center, City of Hope Medical Center, Duarte, CA

Nicola Gökbuget, MD¹, Hervé Dombret, MD, PhD², Massimiliano Bonifacio, MD^3*, Albrecht Reichle, MD^4*, Carlos Graux, MD PhD^5*, Christoph Faul, MD⁶, Helmut Diedrich, MD^7*, Max S. Topp, MD⁸, Monika Brüggemann, MD^9*, Heinz A. Horst, MD, PhD¹⁰, Julia Stieglmaier, PhD^11*, Hendrik Wessels, MD^11*, Vincent Haddad, MSc^12*, Gerhard Zugmaier, MD¹¹, Dirk Nagorsen, MD¹³ and Ralf C Bargou, MD¹⁴

¹Department of Medicine II, Goethe University, Frankfurt, Germany
²Hôpital Saint-Louis, AP-HP, Paris, France
³Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
⁴University Hospital, Regensburg, Germany
⁵Department of Hematology, CHU UcL Namur, Mont-Godinne, Belgium
⁶Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
⁷Medizinische Hochschule, Hannover, Germany
⁸Department of Internal Medicine II, Division of Hematology and Medical Oncology, Wuerzburg University Medical Center, Wuerzburg, Germany
⁹Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
¹⁰Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany
¹¹Amgen Research (Munich) GmbH, Munich, Germany
¹²Amgen Ltd., Cambridge, England
¹³Global Clinical Development, Amgen, Thousand Oaks, CA
¹⁴Department of Hematology and Oncology, University Hospital Wurzburg, Wurzburg, Germany

Stephan A. Grupp, MD, PhD^1,2, Shannon L Maude, MD, PhD^1,2, Pamela A Shaw, PhD^3*, Richard Aplenc, MD, PhD^1,2, David M. Barrett, MD, PhD^2,4*, Colleen Callahan, MSN^2*, Simon F. Lacey, PhD, BS^5*, Bruce L. Levine, PhD⁶, J Joseph Melenhorst, PhD^5*, Laura Motley, RN^2*, Susan R. Rheingold, MD^1,2, David T Teachey, MD^1,2, Patricia A. Wood, MD, PhD⁷, David Porter, MD⁸ and Carl H. June, MD^5,9

¹Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
²Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
³Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
⁴Department of Pediatrics, University of Pennsylvania, Philadelphia, PA
⁵Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁶Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁷Cell & Gene Therapies Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁸Bone Marrow and Stem Cell Transplant Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
⁹Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Jae H Park, MD¹, Isabelle Riviere, PhD², Xiuyan Wang, PhD^2*, Yvette Bernal, MS^3*, Terence Purdon^4*, Elizabeth Halton, RN, MS, ANP^5*, Yongzeng Wang, PhD^2*, Kevin J. Curran, MD⁶, Craig S. Sauter, MD⁷, Michel Sadelain, MD, PhD² and Renier J. Brentjens, MD, PhD²

¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Shannon L Maude, MD, PhD^1,2, David M. Barrett, MD, PhD^1,3*, David E Ambrose^4*, Susan R. Rheingold, MD^1,2, Richard Aplenc, MD, PhD^1,2, David T Teachey, MD^1,2, Colleen Callahan, MSN^1*, Christine S Barker^5*, Maya Mudambi^5*, Pamela A Shaw, PhD^6*, Jennifer Brogdon, PhD^7*, Regina M Young, PhD^4*, John Scholler^4*, Andreas Loew, PhD^7*, Katherine T. Marcucci, PhD^8*, Jeffrey Finklestein^4*, Irina Kulikovskaya, PhD^4*, Farzana Nazimuddin^4*, Zhaohui Zheng, MS^9,10*, Bruce L. Levine, PhD^8,9, David L Porter, MD¹¹, Simon F. Lacey, PhD, BS^10*, Jan J. Melenhorst, PhD^8*, Carl H. June, MD^10,11,12 and Stephan A. Grupp, MD, PhD^1,2

¹Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
²Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
³Department of Pediatrics, University of Pennsylvania, Philadelphia, PA
⁴Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
⁵Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA
⁶Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
⁷Novartis Institute for Biomedical Research, Cambridge, MA
⁸Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁹Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹⁰Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
¹¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹²Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Daniel W. Lee III, MD¹, Maryalice Stetler-Stevenson, MD, PhD², Constance M. Yuan, MD, PhD^2*, Terry J. Fry, M.D.¹, Nirali N Shah, MD¹, Cindy Delbrook, RN^3*, Bonnie Yates, RN, PNP^3*, Hua Zhang, Ph.D.^3*, Ling Zhang, Ph.D.^3*, James N. Kochenderfer, MD⁴, Steven A. Rosenberg, MD, PhD^5*, David Stroncek, MD⁶ and Crystal L. Mackall, MD³

¹Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, National Cancer Institute, Bethesda, MD
³Pediatric Oncology Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD
⁴Experimental Transplantation and Immunology Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD
⁵Surgery Branch, NCI, NIH, Bethesda, MD
⁶Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD